Common use of Increase in Sublicense Payments Clause in Contracts

Increase in Sublicense Payments. Notwithstanding Section 4.1, in the event Licensee directly or indirectly initiates a Challenge in or before any court or patent office, the percentages specified in Section 4.1 shall be increased to the following rates: Sublicense Revenues received by Licensee (on a cumulative basis) Percent of Sublicense Revenues payable to TSRI Up to $[***] [***] $[***] [***] More than $[***] [***] provided, however, that such increase shall only be applied to Sublicense Revenues derived from the Licensed Patent Rights that are the subject of such Challenge (and shall not be applied, for the avoidance of doubt, to Sublicense Revenue derived from any Licensed Patent Rights that are not the subject of such Challenge). Any such increase shall be effective during the pendency of such Challenge from the date Licensee first initiates such Challenge, and thereafter during the term of the Agreement, provided that at least one (I) claim that covers a Licensed Product or Licensed Process within the Licensed Patent Rights being Challenged is held to be valid and enforceable as a result of such Challenge. [***]

Appears in 2 contracts

Samples: License Agreement (Fate Therapeutics Inc), License Agreement (Fate Therapeutics Inc)

AutoNDA by SimpleDocs

Increase in Sublicense Payments. Notwithstanding Section 4.1, in the event Licensee directly or indirectly initiates a Challenge in or before any court or patent office, the percentages specified in Section 4.1 shall be increased to the following rates: Sublicense Revenues received by Licensee (on Licensee(on a cumulative basis) Percent of Sublicense Revenues payable to TSRI Up to $[***] [***] $[***] [***] More than $[***] [***] provided, however, that such increase shall only be applied to Sublicense Revenues derived from the Licensed Patent Rights that are the subject of such Challenge (and shall not be applied, for the avoidance of doubt, to Sublicense Revenue derived from any Licensed Patent * Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission Rights that are not the subject of such Challenge). Any such increase shall be effective during the pendency of such Challenge from the date Licensee first initiates such Challenge, and thereafter during the term of the Agreement, provided that at least one (I1) claim that covers a Licensed Product or Licensed Process within the Licensed Patent Rights being Challenged is held to be valid and enforceable as a result of such Challenge. [***]

Appears in 1 contract

Samples: License Agreement (Fate Therapeutics Inc)

Increase in Sublicense Payments. Notwithstanding Section 4.1, in the event Licensee directly or indirectly initiates a Challenge in or before any court or patent office, the percentages specified in Section 4.1 shall be increased to the following rates: Sublicense Revenues received by Licensee (on a cumulative basis) Licensee(on Percent of Sublicense Revenues payable to * Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission a cumulative basis) TSRI Up to $[***] [***] $[***] [***] More than $[***] [***] provided, however, that such increase shall only be applied to Sublicense Revenues derived from the Licensed Patent Rights that are the subject of such Challenge (and shall not be applied, for the avoidance of doubt, to Sublicense Revenue derived from any Licensed Patent Rights that are not the subject of such Challenge). Any such increase shall be effective during the pendency of such Challenge from the date Licensee first initiates such Challenge, and thereafter during the term of the Agreement, provided that at least one (I1) claim that covers a Licensed Product or Licensed Process within the Licensed Patent Rights being Challenged is held to be valid and enforceable as a result of such Challenge. [***]

Appears in 1 contract

Samples: License Agreement (Fate Therapeutics Inc)

AutoNDA by SimpleDocs

Increase in Sublicense Payments. Notwithstanding Section 4.1, in the event Licensee directly or indirectly initiates a Challenge in or before any court or patent office, the percentages specified in Section 4.1 shall be increased to the following rates: Sublicense Revenues received by Licensee (on Licensee(on a cumulative basis) Percent of Sublicense Revenues payable to TSRI Up to $[***] [***] $[***] [***] More than $[***] [***] provided, however, that such increase shall only be applied to Sublicense Revenues derived from the Licensed Patent Rights that are the subject of such Challenge (and shall not be applied, for the avoidance of doubt, to Sublicense Revenue derived from any Licensed Patent Rights that are not the subject of such Challenge). Any such increase shall be effective during the pendency of such Challenge from the date Licensee first initiates such Challenge, and thereafter during the term of the Agreement, provided that at least one (I1) claim that covers a Licensed Product or Licensed Process within the Licensed Patent Rights being Challenged is held to be valid and enforceable as a result of such Challenge. [***]

Appears in 1 contract

Samples: License Agreement (Fate Therapeutics Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.